Alkermes Announces Updates to Executive Leadership Team
Company for Continued Strong Execution of Business Strategy
Newly Appointed COO and CFO Will Oversee Implementation of Recently Announced Value Enhancement Plan
DUBLIN, Jan. 6, 2021 /PRNewswire/ Alkermes plc (Nasdaq: ALKS), a fully integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology, today announced a series of changes to its executive leadership team. Blair C. Jackson has been appointed chief operating officer (COO) and Iain M. Brown will assume the role of chief financial officer (CFO), replacing James M. Frates. Mr. Frates will leave the company following a 20-year career at Alkermes to pursue another opportunity.